Atria Investments’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$588K Sell
45,208
-624
-1% -$7.1K 0.01% 1434
2026
Q1
$521K Buy
45,832
+933
+2% +$10.1K 0.01% 1427
2025
Q4
$577K Buy
44,899
+4,067
+10% +$50.2K 0.01% 1354
2025
Q3
$456K Buy
+40,832
New +$394K 0.01% 1476

Other funds holding ANGO

Atria Investments's ANGO Position: Q2 2026 in Review

Atria Investments reduced its AngioDynamics (ANGO) stake by 1.4% in Q2 2026, selling an estimated $7.1K and leaving 45,208 shares worth $588K. The position accounts for 0.01% of the portfolio, ranked #1434.

Atria Investments first reported a position in ANGO in Q3 2025 and has held it in 4 quarters since. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Atria Investments held 45,208 shares of AngioDynamics worth $588K as of Q2 2026.
  • Atria Investments sold 624 AngioDynamics shares in Q2 2026, an estimated $7.1K.
  • AngioDynamics made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1434 holding.
  • Atria Investments first reported a position in AngioDynamics in Q3 2025 and has held it in 4 quarters since.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.